Regarding: 'prognostic value of sarcopenia in patients with nasopharyngeal carcinoma: a meta-analysis'.
作者信息
Wu Yuan, Xu Xintian, Jin Xin
机构信息
Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
出版信息
Ann Med. 2025 Dec;57(1):2547095. doi: 10.1080/07853890.2025.2547095. Epub 2025 Aug 18.
Abstract
摘要
相似文献
1
Regarding: 'prognostic value of sarcopenia in patients with nasopharyngeal carcinoma: a meta-analysis'.
Ann Med. 2025 Dec;57(1):2547095. doi: 10.1080/07853890.2025.2547095. Epub 2025 Aug 18.
2
Prognostic value of sarcopenia in patients with nasopharyngeal carcinoma: a meta-analysis.
Ann Med. 2025 Dec;57(1):2530695. doi: 10.1080/07853890.2025.2530695. Epub 2025 Jul 11.
3
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Medicine (Baltimore). 2017 Sep;96(37):e8084. doi: 10.1097/MD.0000000000008084.
4
Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.
Nutrition. 2021 Oct;90:111345. doi: 10.1016/j.nut.2021.111345. Epub 2021 May 21.
5
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Oncotarget. 2017 May 16;8(20):33884-33896. doi: 10.18632/oncotarget.13934.
6
Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review.
Medicina (Kaunas). 2025 Jul 20;61(7):1307. doi: 10.3390/medicina61071307.
7
Sarcopenia is a Prognostic Biomarker for Long-Term Survival after Endovascular Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.
Ann Vasc Surg. 2022 Jul;83:358-368. doi: 10.1016/j.avsg.2022.02.025. Epub 2022 Mar 12.
8
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):3-16. doi: 10.1002/jcsm.13126. Epub 2022 Nov 22.
9
Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.
Int J Surg. 2022 Jan;97:106206. doi: 10.1016/j.ijsu.2021.106206. Epub 2022 Jan 4.
10
Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis.
Nutrition. 2023 Aug;112:112077. doi: 10.1016/j.nut.2023.112077. Epub 2023 May 11.
本文引用的文献
1
Prognostic value of sarcopenia in patients with nasopharyngeal carcinoma: a meta-analysis.
Ann Med. 2025 Dec;57(1):2530695. doi: 10.1080/07853890.2025.2530695. Epub 2025 Jul 11.
2
Pretreatment Computed Tomography-Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis.
Nutr Rev. 2025 May 1;83(5):797-808. doi: 10.1093/nutrit/nuae130.
3
The impact of body composition parameters on severe toxicities in patients with locoregionally advanced nasopharyngeal carcinoma undergoing neoadjuvant chemotherapy.
Ann Transl Med. 2021 Jul;9(14):1180. doi: 10.21037/atm-21-3412.
4
Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
PLoS One. 2021 Jul 19;16(7):e0254844. doi: 10.1371/journal.pone.0254844. eCollection 2021.
5
Is skeletal muscle loss associated with chemoradiotherapy toxicity in nasopharyngeal carcinoma patients? A prospective study.
Clin Nutr. 2021 Jan;40(1):295-302. doi: 10.1016/j.clnu.2020.05.020. Epub 2020 May 21.
Zotero 插件